1. Home
  2. AUPH vs PBH Comparison

AUPH vs PBH Comparison

Compare AUPH & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$16.29

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

HOLD

Current Price

$52.23

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUPH
PBH
Founded
1993
1996
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2014
2004

Fundamental Metrics

Financial Performance
Metric
AUPH
PBH
Price
$16.29
$52.23
Analyst Decision
Buy
Buy
Analyst Count
4
3
Target Price
$17.25
$75.33
AVG Volume (30 Days)
1.2M
512.3K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
5075.00
N/A
EPS
0.53
0.61
Revenue
$283,055,000.00
$975,777,000.00
Revenue This Year
$17.54
N/A
Revenue Next Year
$15.74
$4.31
P/E Ratio
$31.08
$83.95
Revenue Growth
20.38
36.77
52 Week Low
$10.34
$42.62
52 Week High
$19.25
$71.07

Technical Indicators

Market Signals
Indicator
AUPH
PBH
Relative Strength Index (RSI) 54.99 53.30
Support Level $14.61 $50.49
Resistance Level $16.46 $55.99
Average True Range (ATR) 0.48 1.41
MACD 0.10 -0.11
Stochastic Oscillator 50.68 46.44

Price Performance

Historical Comparison
AUPH
PBH

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Share on Social Networks: